meRfi®-GM
Proteobacteria / Pseudomonadota
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Proteobacteria involve Escherichia and Desulfovibrio.
The Proteobacteria showed relatively high abundance in genes involved in degradation of xenobiotics (ko01220), possibly contributing to the degradation of environmental chemicals and pharmaceuticals in the gut
Relative abundance of Proteobacteria in the ecosystem
- Soil: 36.5%
- Plant leaf: 62.0%
- Air: 77.9%
- Ocean: 57.9%
- Freshwater: 61.3%
- Human gut: 4.5%
Shin et al. 2015 Trends Biotechnol 33…
References (Sources)
- 1,520 Reference Genomes from Cultivated Human Gut Bacteria Enable Functional Microbiome Analyse
- How the Interplay Between the Commensal Microbiota, Gut Barrier Integrity, and Mucosal Immunity Regulates Brain Autoimmunity
- IBD—what role do Proteobacteria play?
- Proteobacteria: microbial signature of dysbiosis in gut microbiota